ARA-290: Dosage & Administration
Part of the ARA-290 Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Dosage Protocols
| Indication | Dose | Route | Frequency |
|---|---|---|---|
| Neuropathy (Phase 2) | 2 mg | SC | 3× weekly |
| Metabolic research | 4 mg | SC | Daily |
ARA-290 has a plasma half-life of ~2 minutes, but tissue-level effects persist much longer through downstream IRR signaling cascades.
Preparation
Clinical trial formulations were pre-filled syringes. Research-grade ARA-290 is reconstituted from lyophilized powder with bacteriostatic water. Use the peptide calculator for volumes.
Timing & Cycles
Phase 2 trials used 28-day treatment courses. ARA-290 can be administered at any time of day. Three-times-weekly dosing was effective for neuropathy outcomes despite the short plasma half-life.
Storage
- Lyophilized: -20°C long-term, 2–8°C short-term
- Reconstituted: 2–8°C, use per supplier specifications